New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives ‘FELUDA’, recently received approval from the Drugs Controller General of India for a commercial rollout.
This test kit is developed by scientists at the Delhi-based Institute of Genomics and Integrative Biology, one of the CSIR institutes, would be manufactured by Tata group company in accordance with an agreement that Tata Sons signed with the CSIR institute in May.
“It received regulatory approvals today from the Drug Controller General of India (DCGI) for commercial launch, as per ICMR guidelines, meeting high-quality benchmarks with 96 per cent sensitivity and 98 per cent specificity for detecting the novel coronavirus,” said a PIB press release.
The Tata CRISPR test is the world’s first diagnostic test to deploy a specially-adapted Cas9 protein to successfully detect the virus causing COVID-19, the statement added.
Here are the interesting facts about the testing kit FELUDA:
Bhubaneswar: After several Biju Janata Dal (BJD) leaders blamed VK Pandian for the regional party’s…
Mumbai: The Congress-National Conference (NC) alliance which formed the government in Jammu & Kashmir after winning…
New Delhi: It was the last day in office for Dhananjaya Yeshwant Chandrachud as Chief…
Cuttack: The Orissa High Court has refused to quash a criminal case against a lawyer…
Bhubaneswar: The cyclonic circulation over southwest Bay of Bengal is likely to intensify into a…
Bhubaneswar: Activists of the students’ wing of Odisha Congress staged a demonstration and threw eggs…
Bhubaneswar: Mahila Police in Bhubaneswar on Friday detained a Kashmiri Muslim youth, Samir Mansoor, for…
Keonjhar: A woman Revenue Inspector (RI) reportedly fainted after Ghasipura Tehsildar in Odisha’s Keonjhar district…